Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conditioned medium versus PRP after hair transplantation
IRCT20200127046282N18Phase 2Completed
- Sponsor
- Skin and Stem Cell Research Center
- Start
- Jun 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of ACT-20-CM and platelet-rich plasma in alopecia areata (2 arms), sponsored by Skin and Stem Cell Research Center. Primary endpoints: Hair transplantation result, Side effects and 2 more. Started Jun 2022; status: completed.
02
Drugs
ACT-20-CMplatelet-rich plasma
03
Conditions
alopecia areata
Beyond the preview
Go deeper on IRCT20200127046282N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200127046282N18.